gebhart/patrepeval huggingface dataset:
Degree of polymerization of a vesicle membrane (1984)

ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTDegree of polymerization of a vesicle membraneDurgadas Bolikal and Steven L. RegenCite this: Macromolecules 1984, 17, 6, 1287–1289Publication Date (Print):June 1, 1984Publication History Published online1 May 2002Published inissue 1 June 1984https://pubs.acs.org/doi/10.1021/ma00136a030https://doi.org/10.1021/ma00136a030research-articleACS PublicationsRequest reuse permissionsArticle Views72Altmetric-Citations25LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose Get e-Alerts
The Design and Evolution of C (1994)

PART I. 1. The Prehistory of C++ . 2. C with Classes. 3. The Birth of C++. 4. C++ Language Design Rules. 5. Chronology 1985-1993. 6. Standardization. 7. Interest and Use. 8. Libraries. 9. Looking Ahead. PART II. 1. Memory Management. 2. Overloading. 3. Multiple Inheritance. 4. Class Concept Refinements. 5. Casting. 6. Templates. 7. Exception Handling. 8. Namespaces. 9. The C Preprocessor. Index. 0201543303T04062001
In vitro andin vivo biocompatibility of chitosan-xanthan polyionic complex (2000)

A novel hydrogel, CHITOXAN(TM) (CH-X), has potential as a vehicle for controlled drug delivery. The hydrogel is obtained by complexation of two polysaccharides, chitosan and xanthan. In the present work we investigated the biocompatibility of the complex using in vitro and in vivo models. The cytotoxic effects of CH-X microspheres as well as their degradation products at different concentrations were assessed on fibroblasts (fibroblast cell line L-929) using 3-(4,5-dimethylthiazole-2yl)-2,5-triphenyl tetrazolium) (MTT). The test is based on mitochondrial dehydrogenase cell activity as an indicator of cell viability. Interleukin-1beta (IL-1beta) and tumor necrosis factor-alpha (TNF-alpha) cytokines as well as nitric oxide (NO) production by macrophages (macrophage cell line J-774) were examined as indicators of cell activation. In vivo biocompatibility assessment was performed for 1 to 12 weeks. This study was performed using tablets obtained after compression of CH-X particles implanted at the subcutaneous level in male Wistar rats. CH-X biocompatibility and degradation were investigated using histological studies. Light and transmission electron microscopy (TEM) analyses were used to determine the foreign-body reaction and phagocytosis of the implants by macrophages. Fibroblast exposition to CH-X particles and degradation products did not show cytotoxic effects as measured by MTT test. TNF-alpha production was dependent on CH-X particles concentration, whereas IL-1beta production was found to be dose independent. CH-X extract products stimulated TNF-alpha secretion when used at the highest concentration (10 mg/mL), notably after 28 days' degradation time. No effect was observed on IL-1beta production when CH-X extracts were used in comparison to the control. The effects of CH-X particles on NO secretion were similar as on TNF-alpha. Histological studies showed that CH-X tablets broke down into particles which progressively degraded into smaller fragments. A significant fraction of the fragments was ingested by the macrophages after 12 weeks of implantation. Light microscopy studies showed a weak foreign-body reaction as a function of time and the fibrous layer thickness decreased with time of implantation.
Non-noticeable information embedding in color images: marking and detection (2003)

One of the problems arising from the use of digital media is the ease of obtaining identical copies of digital images or audio files, allowing manipulation and unauthorized use. Copyright is an effective tool for preserving intellectual property of those documents but authors and publishers need effective techniques preventing copyright modification, due to the straightforward access to multimedia applications and the wider use of digital publications through the WWW. These techniques are generally called watermarking and allow the introduction of side information (i.e. author identification, copyrights, dates, etc.). This work concentrates on the problem of watermarking embedding and optimum detection in color images through the use of spread spectrum techniques, both in space (direct sequence spread spectrum or DSSS) and frequency (frequency hopping). It is applied to RGB and opponent color component representations. Perceptive information is considered in both color systems. Some tests are performed in order to ensure imperceptibility and to assess detection quality of the optimum color detectors.
Direct and Natural Killer Cell-Mediated Antitumor Effects of Low-Dose Bortezomib in Hepatocellular Carcinoma (2008)

Low-dose Bortezomib mediates a specific dual antitumor effect in HCC by inhibiting tumor cell proliferation and priming hepatoma cells for NK cell antitumor reactivity. Our data suggest that patients with HCC may benefit from Bortezomib treatment combined with immunotherapeutic approaches such as adoptive NK cell transfer taking advantage of enhanced NKG2D-mediated antitumor immunity.
Selecting patients for cardiac resynchronization therapy: electrical or mechanical dyssynchrony? (2006)

Cardiac resynchronization therapy (CRT) markedly reduces morbidity and mortality in patients with heart failure and prolonged QRS duration. Landmark trials have included over 4000 patients based on their electrocardiogram. A few small, observational, non-randomized, single centre studies of short duration have suggested that echocardiographic measurement of mechanical dyssynchrony may better identify patients likely to benefit from CRT. We objectively review the meaning and measurement of electrical and mechanical dyssynchrony, the strengths and weaknesses of echocardiographic indices of dyssynchrony, and the controversial issue of predicting response to treatment. We conclude that proposals to alter current guidelines for patient selection, and include echocardiography, are misguided. Echocardiographic assessment will only become credible and applicable to clinical practice once used to select patients for large prospective randomized trials which show an improvement in clinical outcome.
Making a Science of Model Search (2012)

Many computer vision algorithms depend on a variety of parameter choices and settings that are typically hand-tuned in the course of evaluating the algorithm. While such parameter tuning is often presented as being incidental to the algorithm, correctly setting these parameter choices is frequently critical to evaluating a method's full potential. Compounding matters, these parameters often must be re-tuned when the algorithm is applied to a new problem domain, and the tuning process itself often depends on personal experience and intuition in ways that are hard to describe. Since the performance of a given technique depends on both the fundamental quality of the algorithm and the details of its tuning, it can be difficult to determine whether a given technique is genuinely better, or simply better tuned. In this work, we propose a meta-modeling approach to support automated hyper parameter optimization, with the goal of providing practical tools to replace hand-tuning with a reproducible and unbiased optimization process. Our approach is to expose the underlying expression graph of how a performance metric (e.g. classification accuracy on validation examples) is computed from parameters that govern not only how individual processing steps are applied, but even which processing steps are included. A hyper parameter optimization algorithm transforms this graph into a program for optimizing that performance metric. Our approach yields state of the art results on three disparate computer vision problems: a face-matching verification task (LFW), a face identification task (PubFig83) and an object recognition task (CIFAR-10), using a single algorithm. More broadly, we argue that the formalization of a meta-model supports more objective, reproducible, and quantitative evaluation of computer vision algorithms, and that it can serve as a valuable tool for guiding algorithm development.
Proteomic Contributions to Personalized Cancer Care (2008)

Cancer impacts each patient and family differently. Our current understanding of the disease is primarily limited to clinical hallmarks of cancer, but many specific molecular mechanisms remain elusive. Genetic markers can be used to determine predisposition to tumor development, but molecularly targeted treatment strategies that improve patient prognosis are not widely available for most cancers. Individualized care plans, also described as personalized medicine, still must be developed by understanding and implementing basic science research into clinical treatment. Proteomics holds great promise in contributing to the prevention and cure of cancer because it provides unique tools for discovery of biomarkers and therapeutic targets. As such, proteomics can help translate basic science discoveries into the clinical practice of personalized medicine. Here we describe how biological mass spectrometry and proteome analysis interact with other major patient care and research initiatives and present vignettes illustrating efforts in discovery of diagnostic biomarkers for ovarian cancer, development of treatment strategies in lung cancer, and monitoring prognosis and relapse in multiple myeloma patients.
Arabidopsis ALF5 , a Multidrug Efflux Transporter Gene Family Member, Confers Resistance to Toxins (2001)

The Arabidopsis genome contains many gene families that are not found in the animal kingdom. One of these is the multidrug and toxic compound extrusion (MATE) family, which has homology with bacterial efflux transporters. Arabidopsis has at least 54 members of this family, which often are found in tandem repeats. Analysis of ALF5, one member of this Arabidopsis family, suggests that its function is required for protection of the roots from inhibitory compounds. Loss of ALF5 function results in the sensitivity of the root to a number of compounds, including a contaminant of commercial agar. Moreover, expression of the Arabidopsis ALF5 cDNA in yeast confers resistance to tetramethylammonium. These phenotypes are consistent with a role for ALF5 as an efflux transporter. Both transcriptional and translational fusions of ALF5 to the beta-glucuronidase reporter gene show that ALF5 is expressed strongly in the root epidermis, a tissue in direct contact with the external environment. The distinct requirement for ALF5 function is remarkable because of the large number of MATE gene family members in Arabidopsis, one of which is adjacent to ALF5 and 83% identical to ALF5 at the amino acid level.
Systems biology of interstitial lung diseases: integration of mRNA and microRNA expression changes (2011)

We present a comprehensive overview of the molecular networks perturbed in ILDs, discuss several potential key molecular regulatory circuits, and identify microRNA species that may play central roles in facilitating the progression of ILDs. These findings advance our understanding of these diseases at the molecular level, provide new molecular signatures in defining the specific characteristics of the diseases, suggest new hypotheses, and reveal new potential targets for therapeutic intervention.
Association of Gene Variants With Incident Myocardial Infarction in the Cardiovascular Health Study (2007)

Although most of the SNPs investigated were not associated with MI in CHS, evidence from this investigation combined with previous studies suggests that 4 of these SNPs are likely associated with MI.
EBV-driven B-cell lymphoproliferative disorders: from biology, classification and differential diagnosis to clinical management (2015)

Epstein-Barr virus (EBV) is a ubiquitous herpesvirus, affecting >90% of the adult population. EBV targets B-lymphocytes and achieves latent infection in a circular episomal form. Different latency patterns are recognized based on latent gene expression pattern. Latent membrane protein-1 (LMP-1) mimics CD40 and, when self-aggregated, provides a proliferation signal via activating the nuclear factor-kappa B, Janus kinase/signal transducer and activator of transcription, phosphoinositide 3-kinase/Akt (PI3K/Akt) and mitogen-activated protein kinase pathways to promote cellular proliferation. LMP-1 also induces BCL-2 to escape from apoptosis and gives a signal for cell cycle progression by enhancing cyclin-dependent kinase 2 and phosphorylation of retinoblastoma (Rb) protein and by inhibiting p16 and p27. LMP-2A blocks the surface immunoglobulin-mediated lytic cycle reactivation. It also activates the Ras/PI3K/Akt pathway and induces Bcl-xL expression to promote B-cell survival. Recent studies have shown that ebv-microRNAs can provide extra signals for cellular proliferation, cell cycle progression and anti-apoptosis. EBV is well known for association with various types of B-lymphocyte, T-lymphocyte, epithelial cell and mesenchymal cell neoplasms. B-cell lymphoproliferative disorders encompass a broad spectrum of diseases, from benign to malignant. Here we review our current understanding of EBV-induced lymphomagenesis and focus on biology, diagnosis and management of EBV-associated B-cell lymphoproliferative disorders.
Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein (1992)

The expression of Gag, Pol, Vif, Vpr, Vpu, and Env proteins from unspliced and partially spliced human immunodeficiency virus type 1 (HIV-1) mRNAs depends on the viral protein Rev, while the production of Tat, Rev, and Nef from multiply spliced mRNAs does not require Rev. To investigate the difference between gag and tat mRNAs, we generated plasmids expressing tat-gag hybrid mRNAs. Insertion of the gag gene downstream of the tat open reading frame in the tat cDNA resulted in the inhibition of Tat production. This inhibition was caused, at least in part, by a decrease in the stability of the produced mRNA. Deletions in gag defined a 218-nucleotide inhibitory sequence named INS-1 and located at the 5' end of the gag gene. Further experiments indicated the presence of more than one inhibitory sequence in the gag-protease gene region of the viral genome. The inhibitory effect of INS-1 was counteracted by the positive effect mediated by the Rev-Rev-responsive element interaction, indicating that this sequence is important for Rev-regulated gag expression. The INS-1 sequence did not contain any known HIV-1 splice sites and acted independently of splicing. It was found to have an unusually high AU content (61.5% AU), a common feature among cellular mRNAs with short half-lives. These results suggest that HIV-1 and possibly other lentiviruses have evolved to express unstable mRNAs which require additional regulatory factors for their expression. This strategy may offer the virus several advantages, including the ability to enter a state of low or latent expression in the host.
Magnesium bioavailability from magnesium citrate and magnesium oxide. (1990)

This study compared magnesium oxide and magnesium citrate with respect to in vitro solubility and in vivo gastrointestinal absorbability. The solubility of 25 mmol magnesium citrate and magnesium oxide was examined in vitro in solutions containing varying amounts of hydrochloric acid (0-24.2 mEq) in 300 ml distilled water intended to mimic achlorhydric to peak acid secretory states. Magnesium oxide was virtually insoluble in water and only 43% soluble in simulated peak acid secretion (24.2 mEq hydrochloric acid/300 ml). Magnesium citrate had high solubility even in water (55%) and was substantially more soluble than magnesium oxide in all states of acid secretion. Reprecipitation of magnesium citrate and magnesium oxide did not occur when the filtrates from the solubility studies were titrated to pH 6 and 7 to stimulate pancreatic bicarbonate secretion. Approximately 65% of magnesium citrate was complexed as soluble magnesium citrate, whereas magnesium complexation was not present in the magnesium oxide system. Magnesium absorption from the two magnesium salts was measured in vivo in normal volunteers by assessing the rise in urinary magnesium following oral magnesium load. The increment in urinary magnesium following magnesium citrate load (25 mmol) was significantly higher than that obtained from magnesium oxide load (during 4 hours post-load, 0.22 vs 0.006 mg/mg creatinine, p less than 0.05; during second 2 hours post-load, 0.035 vs 0.008 mg/mg creatinine, p less than 0.05). Thus, magnesium citrate was more soluble and bioavailable than magnesium oxide.
Impact of assay parameters on the accuracy of free PSA test: Source and stability of calibrator, calibration curve fitting, and level of total PSA in the serum (1998)

The measurement of PSA is recommended for men over 50 years of age for screening of prostate cancer. However, proper differentiation of prostate cancer from benign prostate hyperplasia (BPH) relies on an accurate measurement of free PSA (fPSA) and a correct calculation of percent fPSA. Because of the extremely low concentration of fPSA in the serum, any slight deviation from its true value may produce large errors in percent fPSA calculated. Therefore, we undertook a study examining carefully those parameters of the fPSA assay which might affect the fPSA determination. We found that the integrity of the calibrator, the computer curve-fitting program selected, the source of the calibrator, and the total PSA or fPSA + PSA complexes (tPSA) concentration of the specimen all had an impact on the accuracy of the fPSA value assayed. We found that an examination of the slope of the calibration curve was important to reveal whether the calibrator had or had not been denatured during storage. We also found that the 4-parameter cure fitting program was best suited for plotting the fPSA calibration curve. The calibrator we isolated from LNCaP cells was acceptable for our assay because it had an affinity for the assay antibody very similar to that of serum fPSA. We also determined the effect of tPSA concentration on the fPSA determinations and found that within the concentration range of 4-10 ng/mL the impact on the percent fPSA calculated was not significant. We believe that our assay produces accurate fPSA values when all these assay parameters are well controlled.
A navigation system using projection images of laparoscopic instruments and a surgical target with improved image quality (2008)

We propose a new projector-based augmented reality (PBAR) system which can project the image of forceps and a surgical target simultaneously for support of laparoscopic surgery. A compensation method of an error arisen from motion of a body is also proposed to improve the quality of the projection images. It is shown that the system is significant for the forceps insertion by the experiments using the dry-box.
Putting it Simply: a Context-Aware Approach to Lexical Simplification (2011)

We present a method for lexical simplification Simplification rules are learned from a comparable corpus, and the rules are applied in a context-aware fashion to input sentences. Our method is unsupervised. Furthermore, it does not require any alignment or correspondence among the complex and simple corpora. We evaluate the simplification according to three criteria: preservation of grammaticality, preservation of meaning, and degree of simplification Results show that our method outperforms an established simplification baseline for both meaning preservation and simplification, while maintaining a high level of grammaticality.
Inhibition of Immune Thrombocytopenic Purpura (ITP) by an Orally Bioavailable Inhibitor of Syk Kinase Activity. (2005)

Abstract Immune Thrombocytopenic Purpura (ITP) is an autoimmune disease characterised by the destruction of platelets by pathogenic autoantibodies. Clearance of platelets by phagocytic cells such as macrophages occurs through activating receptors for the Fc portion of IgG (FcγR). A central tyrosine kinase in this activation pathway is Syk, which is required for FcγR-mediated phagocytosis; thus, we questioned whether inhibition of Syk would ameliorate ITP. R406 is an orally bioavailable Syk-kinase inhibitor which is well tolerated by human volunteers. Using a well-described murine model of ITP, we tested the ability of R788 (the prodrug of R406) to ameliorate thrombocytopenia. Mice injected with an antibody directed to integrin αIIβ were profoundly thrombocytopenic when platelets were enumerated 24 hr post injection. However, mice pre-treated with 25 or 40 mg/kg R788 were protected from thrombocytopenia. Mice pre-treated with the vehicle alone displayed no protection. It has been demonstrated that chimeric Syk deficient mice display a bleeding diathesis; it was therefore questioned whether treatment of mice would demonstrate prolonged tail vein bleeding time. In independent experiments, mice treated with the with the bioavailable inhibitor R406 had no significant difference in bleeding time compared to untreated mice or mice treated with vehicle alone. Syk is also involved in collagen-induced platelet secretion and aggregation. To further the potential use of this drug in humans, the ability of platelets derived from human volunteers treated with R788 to respond to in vitro collagen-induced aggregation was analysed. Platelets from volunteers treated with the drug displayed normal collagen (as well as ADP)-induced platelet aggregation compared to untreated volunteers or those treated with the vehicle alone. These data suggest that future investigation of Syk inhibition in autoimmune diseases such as ITP is warranted.